These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12591503)

  • 1. Expression of HLA class I-specific natural killer cell receptors on peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation.
    Tanaka J; Tsutsumi Y; Zhang L; Kato N; Mori A; Ohta S; Toyoshima N; Asaka M; Imamura M
    Transplant Proc; 2003 Feb; 35(1):497-8. PubMed ID: 12591503
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors.
    Vitale C; Pitto A; Benvenuto F; Ponte M; Bellomo R; Frassoni F; Mingari MC; Bacigalupo A; Moretta L
    Hematol J; 2000; 1(2):136-44. PubMed ID: 11920181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased proportion of HLA-class-I-specific natural killer cell receptors (CD94) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation.
    Tanaka J; Tutumi Y; Zhang L; Mori A; Kahata K; Toyoshima N; Ohta S; Kobayashi S; Hashino S; Asaka M; Imamura M
    Acta Haematol; 2001; 105(2):89-91. PubMed ID: 11408710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation.
    Wang JW; Howson JM; Ghansah T; Desponts C; Ninos JM; May SL; Nguyen KH; Toyama-Sorimachi N; Kerr WG
    Science; 2002 Mar; 295(5562):2094-7. PubMed ID: 11896280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease.
    Kordelas L; Steckel NK; Horn PA; Beelen DW; Rebmann V
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation.
    Albi N; Ruggeri L; Aversa F; Merigiola C; Tosti A; Tognellini R; Grossi CE; Martelli MF; Velardi A
    Blood; 1996 May; 87(9):3993-4000. PubMed ID: 8611732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HLA-C-specific natural killer cell receptors (CD158a and CD158b) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation.
    Tanaka J; Mori A; Ohta S; Yamamoto Y; Kobayashi S; Hashino S; Kobayashi M; Asaka M; Imamura M
    Br J Haematol; 2000 Mar; 108(4):778-83. PubMed ID: 10792283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cells expressing killer cell inhibitory receptors after allogeneic bone marrow transplantation.
    Tanaka J; Kobayashi S; Mori A; Ohta S; Hashino S; Kasai M; Asaka M; Imamura M
    Transplant Proc; 2000 Nov; 32(7):2447. PubMed ID: 11120237
    [No Abstract]   [Full Text] [Related]  

  • 9. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
    Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
    Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of donor NK and T cells infused in patients undergoing MHC-matched allogeneic hematopoietic transplantation.
    Pascal V; Brunet C; Pradel V; Thirion X; Andre P; Faucher C; Sampol J; Dignat-George F; Blaise D; Vivier E; Chabannon C
    Leukemia; 2002 Nov; 16(11):2259-66. PubMed ID: 12399971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of soluble HLA-G and HLA-G receptors in patients with hematological malignancies after allogeneic stem cell transplantation.
    Biedroń M; Rybka J; Wróbel T; Prajs I; Poręba R; Kuliczkowski K
    Med Oncol; 2015 Aug; 32(8):219. PubMed ID: 26187179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytokines and major histocompatibility complex antigens in graft-versus-host disease: in vitro studies using T-cell lines and keratinocytes or hemopoietic targets.
    Huber C; Niederwieser D
    Haematol Blood Transfus; 1990; 33():652-4. PubMed ID: 2182455
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequential analysis of HLA-C-specific killer cell inhibitory receptor (CD158b) expressing peripheral blood mononuclear cells during chronic graft-versus-host disease.
    Tanaka J; Tutumi Y; Mori A; Ohta S; Kobayashi S; Asaka M; Imamura M
    Bone Marrow Transplant; 2000 Aug; 26(3):287-90. PubMed ID: 10967567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-E is the ligand for the natural killer cell CD94/NKG2 receptors.
    Posch PE; Borrego F; Brooks AG; Coligan JE
    J Biomed Sci; 1998; 5(5):321-31. PubMed ID: 9758906
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation.
    Shaffer BC; Le Luduec JB; Forlenza C; Jakubowski AA; Perales MA; Young JW; Hsu KC
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):705-709. PubMed ID: 26772158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.
    Held W; Cado D; Raulet DH
    J Exp Med; 1996 Nov; 184(5):2037-41. PubMed ID: 8920892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid resistance and the Ly-49 family of natural killer cell receptors.
    Yokoyama WM
    J Exp Med; 1995 Aug; 182(2):273-7. PubMed ID: 7629493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.